ARC
Advisor Resource Council’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-65,388
| Closed | -$1.55M | – | 445 |
|
|
2025
Q1 | $1.55M | Buy |
+65,388
| New | +$1.55M | 0.13% | 183 |
|
|
2024
Q4 | – | Sell |
-7,901
| Closed | -$229K | – | 206 |
|
|
2024
Q3 | $229K | Buy |
+7,901
| New | +$229K | 0.1% | 204 |
|
|
2024
Q2 | – | Sell |
-10,011
| Closed | -$288K | – | 167 |
|
|
2024
Q1 | $288K | Sell |
10,011
-10,557
| -51% | -$304K | 0.12% | 171 |
|
|
2023
Q4 | $592K | Buy |
20,568
+12,075
| +142% | +$348K | 0.07% | 251 |
|
|
2023
Q3 | $282K | Sell |
8,493
-1,460
| -15% | -$48.4K | 0.15% | 110 |
|
|
2023
Q2 | $365K | Sell |
9,953
-3,888
| -28% | -$143K | 0.16% | 97 |
|
|
2023
Q1 | $578K | Buy |
13,841
+3,321
| +32% | +$139K | 0.15% | 160 |
|
|
2022
Q4 | $539K | Buy |
10,520
+77
| +0.7% | +$3.95K | 0.26% | 73 |
|
|
2022
Q3 | $457K | Sell |
10,443
-23,628
| -69% | -$1.03M | 0.31% | 85 |
|
|
2022
Q2 | $1.79M | Buy |
34,071
+947
| +3% | +$49.6K | 0.17% | 138 |
|
|
2022
Q1 | $1.72M | Sell |
33,124
-23,917
| -42% | -$1.24M | 0.52% | 53 |
|
|
2021
Q4 | $3.37M | Buy |
57,041
+22,572
| +65% | +$1.33M | 0.26% | 80 |
|
|
2021
Q3 | $1.48M | Sell |
34,469
-13,407
| -28% | -$576K | 0.45% | 61 |
|
|
2021
Q2 | $1.87M | Buy |
+47,876
| New | +$1.87M | 0.2% | 116 |
|